Clinical applications of indocyanine green fluorescence for the treatment of hepatocellular carcinoma

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 1

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Field of Vision

World J Gastrointest Oncol. Jan 15, 2026; 18(1): 114339
Published online Jan 15, 2026. doi: 10.4251/wjgo.v18.i1.114339

Full Size Figure Download Figure

Figure 3 Indocyanine green evolution timeline. ICG: Indocyanine green; MILS: Minimally invasive liver surgery; FDA: Food and Drug Administration.

Citation: Piccolo G, Barabino M, Benuzzi L, Formisano G, Bianchi PP. Clinical applications of indocyanine green fluorescence for the treatment of hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(1): 114339
URL: https://www.wjgnet.com/1948-5204/full/v18/i1/114339.htm
DOI: https://dx.doi.org/10.4251/wjgo.v18.i1.114339

Piccolo G, Barabino M, Benuzzi L, Formisano G, Bianchi PP. Clinical applications of indocyanine green fluorescence for the treatment of hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(1): 114339 [PMID: 41607756 DOI: 10.4251/wjgo.v18.i1.114339]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.